<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Aurgalys &#187; Opinion</title>
	<atom:link href="http://www.aurgalys.com/category/opinion/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.aurgalys.com</link>
	<description>Entrepreneurs Serving Entrepreneurs</description>
	<lastBuildDate>Wed, 28 Jul 2010 16:40:06 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>July 10th, 2009: Venture capital and the French paradox</title>
		<link>http://www.aurgalys.com/2009/12/july-10th-2009-venture-capital-and-the-french-paradox/</link>
		<comments>http://www.aurgalys.com/2009/12/july-10th-2009-venture-capital-and-the-french-paradox/#comments</comments>
		<pubDate>Thu, 03 Dec 2009 15:17:13 +0000</pubDate>
		<dc:creator>esquivel</dc:creator>
				<category><![CDATA[Opinion]]></category>

		<guid isPermaLink="false">http://www.aurgalys.com/?p=996</guid>
		<description><![CDATA[July 10th, 2009: Venture capital and the French paradox
Companies are thinking of relocating to France or European Union in order to benefit the private equity funds available there. Philippe Berthon, a board member of France Biotech and Aurgalys General Partner explains.
read more
]]></description>
		<wfw:commentRss>http://www.aurgalys.com/2009/12/july-10th-2009-venture-capital-and-the-french-paradox/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>March 16, 2009: Since 1997, FCPI funds have profoundly impacted on venture funding  in France and Europe.</title>
		<link>http://www.aurgalys.com/2009/03/since-1997-fcpi-funds-have-profoundly-impacted-on-venture-funding-in-france-and-europe/</link>
		<comments>http://www.aurgalys.com/2009/03/since-1997-fcpi-funds-have-profoundly-impacted-on-venture-funding-in-france-and-europe/#comments</comments>
		<pubDate>Mon, 16 Mar 2009 09:03:51 +0000</pubDate>
		<dc:creator>esquivel</dc:creator>
				<category><![CDATA[Opinion]]></category>

		<guid isPermaLink="false">http://www.aurgalys.com/?p=729</guid>
		<description><![CDATA[March 16, 2009 &#8211; FCPI were launched in 1997. According to a study published in March 2009 by AFIC and OSEO on the 1997-2007 period, 4.4 billion Euros have been collected and 2.2 billion Euros were invested in more than 800 innovative private companies. In 2007 alone, 624 million Euros were raised through 28 FCPI [...]]]></description>
		<wfw:commentRss>http://www.aurgalys.com/2009/03/since-1997-fcpi-funds-have-profoundly-impacted-on-venture-funding-in-france-and-europe/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Jan 21, 2009:&#160;&#187;In France, in 2009, we expect up to two life science company take over ranging 75-200M €&#160;&#187;</title>
		<link>http://www.aurgalys.com/2009/01/we-are-starting-a-2nd-round-cycle/</link>
		<comments>http://www.aurgalys.com/2009/01/we-are-starting-a-2nd-round-cycle/#comments</comments>
		<pubDate>Wed, 21 Jan 2009 15:24:49 +0000</pubDate>
		<dc:creator>esquivel</dc:creator>
				<category><![CDATA[Opinion]]></category>

		<guid isPermaLink="false">http://www.aurgalys.com/2009/02/we-are-starting-a-2nd-round-cycle/</guid>
		<description><![CDATA[Jan 21, 2009: Interview Easybourse, Philippe Berthon, Aurgalys Partner,  &#171;&#160;In France, in 2009, we expect up to two life science company take over  ranging 75-200M €&#160;&#187; .
You can read it (in French), by clicking here .
]]></description>
		<wfw:commentRss>http://www.aurgalys.com/2009/01/we-are-starting-a-2nd-round-cycle/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Jan 16, 2009: Relationship between Biotech and Venture Capital</title>
		<link>http://www.aurgalys.com/2009/01/relationship-between-biotech-and-venture-capital/</link>
		<comments>http://www.aurgalys.com/2009/01/relationship-between-biotech-and-venture-capital/#comments</comments>
		<pubDate>Fri, 16 Jan 2009 20:45:39 +0000</pubDate>
		<dc:creator>esquivel</dc:creator>
				<category><![CDATA[Opinion]]></category>

		<guid isPermaLink="false">http://www.aurgalys.com/?p=623</guid>
		<description><![CDATA[If you wonder what is a biotech company , why Venture Capital are compulsoryÂ  for the growth of the biotech companies in general, have a look to thatÂ  video (in french).

]]></description>
		<wfw:commentRss>http://www.aurgalys.com/2009/01/relationship-between-biotech-and-venture-capital/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
